Dingdang Health Technology Group Ltd. (HKG:9886)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7950
-0.0050 (-0.63%)
Sep 11, 2026, 4:08 PM HKT

HKG:9886 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,9704,8884,6694,8574,3293,679
Revenue Growth
1.68%4.68%-3.86%12.19%17.68%65.07%
Gross Profit
1,7871,7241,5381,5111,4501,162
Operating Income
10.94-53.44-215.18-278.25-326.42-660.65
Net Income
-61.72-49.02-376.5-225.81-2,833-1,578
Earnings Per Share
-0.05-0.04-0.28-0.17-3.37-3.31
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceutical and Healthcare Business
4,8294,7454,5404,7184,2023,561
Others
140.57143.19129.46139.21127.46117.35
Total
4,9704,8884,6694,8574,3293,679

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,1291,0891,2181,3291,3481,553
Total Debt
261.79281.81152.61140.21163.144,808
Net Cash (Debt)
866.96807.331,0651,1891,185-3,255
Net Cash Growth
7.39%-24.22%-10.41%0.38%--
Net Cash Per Share
0.680.620.810.891.41-6.82

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
116.64136.82-11.35-5.24-237.87-295.49
Capital Expenditures
-26.33-26.33-17.13-13.86-17.7-20.47
Free Cash Flow
90.31110.49-28.48-19.1-255.57-315.96
Free Cash Flow Growth
-18.26%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
35.96%35.26%32.95%31.10%33.49%31.60%
Operating Margin
0.22%-1.09%-4.61%-5.73%-7.54%-17.96%
Pretax Margin
-0.91%-0.63%-7.93%-4.55%-65.42%-43.00%
Profit Margin
-1.24%-1.00%-8.06%-4.65%-65.45%-42.90%
FCF Margin
1.82%2.26%-0.61%-0.39%-5.90%-8.59%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
22.6748.08----
P/FCF Ratio
9.4611.40----
PS Ratio
0.170.260.130.503.19-